Xiaojie Ding

1.3k total citations
45 papers, 1.0k citations indexed

About

Xiaojie Ding is a scholar working on Immunology, Dermatology and Molecular Biology. According to data from OpenAlex, Xiaojie Ding has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 15 papers in Dermatology and 12 papers in Molecular Biology. Recurrent topics in Xiaojie Ding's work include Psoriasis: Treatment and Pathogenesis (13 papers), Dermatology and Skin Diseases (12 papers) and Pharmacological Effects of Natural Compounds (5 papers). Xiaojie Ding is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (13 papers), Dermatology and Skin Diseases (12 papers) and Pharmacological Effects of Natural Compounds (5 papers). Xiaojie Ding collaborates with scholars based in China, United States and Singapore. Xiaojie Ding's co-authors include Jinghai Wu, Elizabeth R. Walsh, Corey M. Carlson, Bart T. Endrizzi, Jerry B. Lingrel, Kristin A. Hogquist, Stephen C. Jameson, Michael Weinreich, Maqsood A. Wani and Bin Li and has published in prestigious journals such as Nature, Journal of Agricultural and Food Chemistry and Chemical Engineering Journal.

In The Last Decade

Xiaojie Ding

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojie Ding China 15 510 377 172 100 94 45 1.0k
Sascha Jakob Germany 16 181 0.4× 478 1.3× 59 0.3× 79 0.8× 55 0.6× 23 1.1k
Lingyan Zhu China 18 282 0.6× 284 0.8× 195 1.1× 23 0.2× 99 1.1× 30 945
Motohiko Oshima Japan 11 169 0.3× 237 0.6× 62 0.4× 28 0.3× 85 0.9× 28 578
Arindam Dhar United States 12 117 0.2× 595 1.6× 225 1.3× 55 0.6× 19 0.2× 35 903
Chi Sun China 20 186 0.4× 461 1.2× 194 1.1× 18 0.2× 27 0.3× 80 1.2k
Xi Huang China 17 139 0.3× 340 0.9× 199 1.2× 11 0.1× 53 0.6× 45 711
Xinhai Yang United States 18 106 0.2× 354 0.9× 315 1.8× 16 0.2× 88 0.9× 22 923
Domenico Liguoro Italy 19 256 0.5× 630 1.7× 307 1.8× 12 0.1× 256 2.7× 42 1.4k
Fanny L. Casado Peru 16 177 0.3× 278 0.7× 93 0.5× 9 0.1× 114 1.2× 32 789
Çagatay Güneş Germany 20 113 0.2× 631 1.7× 182 1.1× 10 0.1× 147 1.6× 51 1.3k

Countries citing papers authored by Xiaojie Ding

Since Specialization
Citations

This map shows the geographic impact of Xiaojie Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojie Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojie Ding more than expected).

Fields of papers citing papers by Xiaojie Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojie Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojie Ding. The network helps show where Xiaojie Ding may publish in the future.

Co-authorship network of co-authors of Xiaojie Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojie Ding. A scholar is included among the top collaborators of Xiaojie Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojie Ding. Xiaojie Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Xiaoying, Ping Xia, Ning Huang, et al.. (2025). A Randomized Controlled Trial for the Optimal Implementation of Psoriasis Treatment by Integrating Chinese and Western Medicine. PubMed. Volume 15. 55–66. 1 indexed citations
2.
Zhao, Rui, et al.. (2025). A progressive defense strategy for fabricating durable superhydrophobic coatings with multifunctional applications. Chemical Engineering Journal. 524. 169300–169300.
3.
Chen, Yiran, Xiaofan Yang, Xiaojie Ding, et al.. (2025). Efficacy and safety of Kangfuxin liquid for eczema: a systematic review and meta-analysis. Archives of Dermatological Research. 317(1). 608–608.
4.
Ding, Xiaojie, Xinchun Li, Yan Li, et al.. (2025). A novel self-assembled nanocarrier-mediated dsRNA fungicide for broad-spectrum management of Rhizoctonia solani. Materials Today Bio. 34. 102099–102099. 2 indexed citations
5.
Wang, Yan, et al.. (2024). Synthesis, Anti-TMV Activities, and Action Mechanisms of a Novel Cytidine Peptide Compound. Journal of Agricultural and Food Chemistry. 72(38). 20783–20793. 1 indexed citations
6.
Liu, Jiali, et al.. (2024). Redesigning transamination and decarboxylation characteristics of L-aspartate aminotransferase by site directed mutation of non-active site. Molecular Catalysis. 553. 113781–113781. 3 indexed citations
7.
8.
Wu, Xinxin, Qi Zheng, Jiankun Song, et al.. (2023). The therapeutic efficacy and mechanism action of Si Cao formula in the treatment of psoriasis: A pilot clinical investigation and animal validation. Journal of Ethnopharmacology. 323. 117662–117662. 4 indexed citations
9.
Chen, Yiran, Xiao Miao, Yan‐Wei Xiang, et al.. (2023). Qinzhu Liangxue inhibits IL-6-induced hyperproliferation and inflammation in HaCaT cells by regulating METTL14/SOCS3/STAT3 axis. Journal of Ethnopharmacology. 317. 116809–116809. 13 indexed citations
10.
Zhou, Mi, Ying Zhang, Zhan Zhang, et al.. (2022). Identification of the potential mechanisms of Huzhang Tongfeng Granules against acute gouty arthritis through network pharmacology and in vivo analysis. Pharmacological Research - Modern Chinese Medicine. 4. 100131–100131. 1 indexed citations
11.
Liu, Liu, Siting Chen, Jiao Wang, et al.. (2022). Fibrinogen-Like Protein 1 as a Novel Biomarker of Psoriasis Severity. Journal of Inflammation Research. Volume 15. 4637–4647. 9 indexed citations
12.
Wang, Jiao, Shuo Zhang, Meng Xing, et al.. (2022). Current evidence on the role of lipid lowering drugs in the treatment of psoriasis. Frontiers in Medicine. 9. 900916–900916. 15 indexed citations
13.
Ru, Yi, Xiaojie Ding, Ying Luo, et al.. (2021). Adverse Events Associated With Anti-IL-23 Agents: Clinical Evidence and Possible Mechanisms. Frontiers in Immunology. 12. 670398–670398. 23 indexed citations
14.
Ding, Xiaojie, Jia Chen, Le Kuai, et al.. (2020). CD4/CD8 dual-positive mycosis fungoides. Medicine. 99(42). e22786–e22786. 3 indexed citations
15.
Zhou, Mi, Xin Li, Xi Chen, et al.. (2020). Huzhang Tongfeng Granule Improves Monosodium Urate‐Induced Inflammation of Gouty Arthritis Rat Model by Downregulation of Cyr61 and Related Cytokines. Evidence-based Complementary and Alternative Medicine. 2020(1). 9238797–9238797. 15 indexed citations
16.
Kanwal, Madiha, Xiaojie Ding, Zhanshan Ma, et al.. (2017). Characterization of germline mutations in familial lung cancer from the Chinese population. Gene. 641. 94–104. 20 indexed citations
17.
Ding, Xiaojie, et al.. (2016). The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer. OncoTargets and Therapy. 9. 1189–1189. 18 indexed citations
18.
Chu, Minjie, Chongqi Sun, Weihong Chen, et al.. (2015). Personal exposure to PM2.5, genetic variants and DNA damage: A multi-center population-based study in Chinese. Toxicology Letters. 235(3). 172–178. 39 indexed citations
19.
Zhu, Meng, Minjie Chu, Chongqi Sun, et al.. (2014). Genetic variants in SMARC genes are associated with DNA damage levels in Chinese population. Toxicology Letters. 229(2). 327–332. 7 indexed citations
20.
Liang, Yurong, Minxia Liu, Pin Wang, Xiaojie Ding, & Yi Cao. (2012). Analysis of 20 genes at chromosome band 12q13: RACGAP1 and MCRS1 overexpression in nonsmall‐cell lung cancer. Genes Chromosomes and Cancer. 52(3). 305–315. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026